Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT04903535

External Nitric Oxide Measurement Through SNO Degradation

In this study, we aim to explore the feasibility of a novel, noninvasive SNO assay to acquire physiological SNO quantification from various parts of the human body and test this new method of analysis. This study aims to help with the currently cumbersome and invasive procedures used to measure SNOs in the body. The proposed activities do not unnecessarily duplicate previous experiments.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Age range

1 day–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Riley Hospital for Children, Indianapolis, Indiana, United States

Loading trial locations.

About this study

S-nitrosylation is the covalent attachment of a nitric oxide group to cystine thiol within a protein to form an S-nitrosothiol (SNO); it has diverse regulatory roles in all mammalian cells and thus operates as a fundamental mechanism for cellular signaling and accounts for a large part of nitric oxide activity. Though SNOs are relevant to many biological disciplines like neuronal, muscular, respiratory, and cardiovascular biology, currently there is no way to measure SNOs that is both easy to use in a clinical setting and accurate in detecting low concentrations; detection is challenging due to the labile nature of the molecules. Low or high concentrations of these molecules could be vital indicators of incoming dangerous issues in the body. A system to easily and accurately measure SNOs could prove useful in preventative treatments. Ultra Violet (UV) light can break SNOs and can be used to measure nitric oxide release, but this method is not fully developed and further research is needed on the potential effect for UV to measure nitric oxide release.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult males or females age ≥ 1 day and ≤ 75 years at time of enrollment

Exclusion criteria

  • Subjects meeting the following criteria will be excluded:
  • Smokers.
  • Any chronic skin conditions.
  • Pregnant.
  • Subjects that are unable or unwilling to cooperate with specimen collection.
  • Subjects with diagnosis of any medical condition that in the investigator's opinion would make them unsuitable for study participation.
  • (for subjects ≥ 18) Subjects that lack the capacity to consent for themselves.

Treatment and study plan

Alonefire SV003 10W 365nm UV Flashlight

Device

Investigator will use a Nitric Oxide Analyzer while attached to a small suction port on the subject's ear lobe to be tested for Nitric Oxide. After getting the baseline assay, the investigator will shine a low-intensity UV Flashlight (Alonefire SV003 10W 365nm UV Flashlight) at the ear lobe for 10 seconds, repeated three times at 20 second intervals, to determine if there is photobleaching. Then the assay will then be performed on the opposite ear lobe. Fifteen minutes after the third UV flashlight exposure, the investigator will collect air from the subject's ear during photolysis into a 20mL glass syringe (once from each ear). Fifteen minutes after the third UV flashlight exposure, the investigator will collect air from the subject's ear during photolysis into a 20mL glass syringe (once from each ear). The subject and the investigator will wear UV goggles during the experiment.

Primary outcomes

  1. Change in Nitric Oxide during UV light exposure

    Time frame: 30 minutes

    NO evolved during UV light exposure from the human ear lobe, hand or forehead.

Sponsors and collaborators

Lead sponsor

Indiana University

Other

Registry information

Official study title

Does a Flashlight Used to Detect Pet Biological Fluids on Human Skin and Other Surfaces Increase Gas Phase Nitric Oxide Levels?

Important dates

Study start
2021
Primary completion
2026
Study completion
2026
First posted
May 26, 2021
Registry last updated
Feb 9, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.